Key result
Cardiac resynchronization therapy optimizes ventricular function and provides well-established long-term benefits for patients with systolic heart failure.
Cardiac resynchronization therapy provides well-established long-term benefits in patient outcomes for systolic heart failure by reducing ventricular dyssynchronous contraction.
Reaffirms CRT benefits in systolic HF; confirms consensus from prior data but leaves open questions for contemporary trials.
Conduction abnormalities, commonly seen in systolic heart failure, lead to delayed activation of the myocardium as the electrical impulse spreads slowly without the aid of healthy conduction tissue. The resulting dyssynchronous ventricular contraction is mechanically less efficient, reducing systolic function and impairing diastolic filling. Simultaneous pacing of the right and left ventricles (i.e., biventricular pacing) reduces ventricular dyssynchronous contraction, overcoming these consequences of conduction delay. An important role for implantable rhythm-management devices providing cardiac resynchronization therapy has emerged in the optimization of ventricular function in heart failure. Long-term benefits in patient outcomes have been well established. With increasing use, understanding of cardiac resynchronization therapy devices and the principles behind the therapy are important for physicians providing perioperative and intensive care for patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2010) conducted a review in Heart Failure. Cardiac Resynchronization Therapy was evaluated. Cardiac resynchronization therapy optimizes ventricular function and provides well-established long-term benefits for patients with systolic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: